GH1 and metabolic dysfunction-associated steatohepatitis: In simple steatosis and early metabolic dysfunction-associated steatohepatitis (MASH), many of the body composition and metabolic features predisposing to MASLD/MASH contribute to decreased GH and IGF-I levels.